Karolinska Development
Karolinska Development, renamed KDventures AB (Nasdaq Stockholm: KDV) in January 2026, is a Solna-based listed life-science investment company founded in 2003 that takes direct minority-to-majority equity stakes in Nordic biotech and medtech companies, several sourced from Karolinska Institutet research, and realises value through licensing deals, trade sales and IPOs.
Karolinska Development is a Solna venture capital firm with €92M AUM and 8 active companies.
Sector breakdown
8 companiesGeography breakdown
3 geographiesKey facts
Recent exits
No exits recorded yet.
Coverage notes
1 fund tracked, 8 portfolio companies (8 active · 0 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Karolinska Development has raised, with its portfolio companies. Hand-checked from public filings.
Karolinska DevelopmentActiveLife Sciences VC20038 assetsLife Sciences VC2003 · 23yr–8–
Unrealized
8 held| Company | Entry |
|---|---|
| AnaCardio Biotech · Sweden | 2021 |
| Aprea Therapeutics Biotech · US | 2003 |
| Biosergen Biotech · Sweden | 2004 |
| BOOST Pharma Biotech · Denmark | 2024 |
| Modus Therapeutics Biotech · Sweden | 2011 |
| OssDsign MedTech · Sweden | 2011 |
| PharmNovo Biotech · Sweden | 2022 |
| SVF Vaccines Biotech · Sweden | 2020 |
Frequently asked questions
- What investment strategy does Karolinska Development focus on?
- Karolinska Development focuses on VC strategies in the private equity space.
- How many portfolio companies does Karolinska Development have?
- Karolinska Development has 8 active portfolio companies and 1 fund tracked on GP Intel.
- Where is Karolinska Development headquartered?
- Karolinska Development is headquartered in Solna, Sweden.
- What is Karolinska Development's assets under management?
- Karolinska Development manages approximately €92M in assets under management.
- When was Karolinska Development founded?
- Karolinska Development was founded in 2003.
- What sectors does Karolinska Development invest in?
- Karolinska Development invests across Healthcare.
Similar firms
Other private equity firms tracked on GP Intel.